We are live on ! Find out more
IVDA icon

Iveda Solutions

11 hedge funds and large institutions have $656K invested in Iveda Solutions in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

81% more capital invested

Capital invested by funds: $362K → $656K (+$295K)

22% more funds holding

Funds holding: 911 (+2)

4.58% less ownership

Funds ownership: 9.58%5% (-4.6%)

Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

IVDA Hedge Fund Activity: Q4 2024 in Review

11 of the 7,609 institutional investors tracked by Wall St. Rank reported a position in Iveda Solutions (IVDA) for Q4 2024, worth a combined $656K — up 81% from $362K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IVDA positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $43.9K. The largest seller was Armistice Capital, exiting entirely with an estimated $217K sold.

  • 11 institutional investors held Iveda Solutions (IVDA) as of Q4 2024, up from 9 in Q3 2024.
  • Funds reported $656K of Iveda Solutions stock for Q4 2024, up 81% quarter-over-quarter.
  • 4 funds opened new Iveda Solutions positions in Q4 2024 and 2 closed out, a net change of +2 holders.
  • The largest Iveda Solutions buyer in Q4 2024 was UBS Group, an estimated $43.9K added.
  • The largest Iveda Solutions seller in Q4 2024 was Armistice Capital, an estimated $217K sold.

Based on aggregated 13F filings for Q4 2024.